Lilly and AstraZeneca Expand Immuno-Oncology Research Collaboration with New Combinations
Go back to Lilly and AstraZeneca Expand Immuno-Oncology Research Collaboration with New Combinations| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 8,203 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 8,203 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1152.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.93 | 52 Week High | $88.16 | |||
| Open | $1152.93 | 52 Week Low | $67.88 | |||
| Day High | $1152.93 | P/E | 266.88 | |||
| Day Low | $1152.93 | EPS | $4.32 | |||
| Volume | 5,983 | |||||

